Tris-(β-mercaptopropyl)-pentaerythritol-aether | 55937-06-9

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: Tris-(β-mercaptopropyl)-pentaerythritol-aether
• 英文别名: 3-(3-Sulfanylpropoxy)-2,2-bis(3-sulfanylpropoxymethyl)propan-1-ol
• CAS: 55937-06-9
• 化学式: C₁₄H₃₀O₄S₃
• 分子量: 358.588
• InChiKey: NULJCQIIEHDLEU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.2
• 重原子数：
  21
• 可旋转键数：
  16
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  50.9
• 氢给体数：
  4
• 氢受体数：
  7

反应信息

• 作为产物：
  描述：

  季戊四醇三烯丙基醚 在 硫化氢 、 亚磷酸三乙酯 作用下， 反应 0.17h， 生成 Tris-(β-mercaptopropyl)-pentaerythritol-aether 、 2-[3-[3-[2-(Hydroxymethyl)-3-(3-sulfanylpropoxy)-2-(3-sulfanylpropoxymethyl)propoxy]propylsulfanyl]propoxymethyl]-3-(3-sulfanylpropoxy)-2-(3-sulfanylpropoxymethyl)propan-1-ol
  参考文献：
  名称：

  [EN] METHODS OF MERCAPTANIZING UNSATURATED COMPOUNDS AND COMPOSITIONS PRODUCED THEREFROM
  [FR] PROCÉDÉS VISANT À MERCAPTANISER DES COMPOSÉS INSATURÉS ET COMPOSITIONS PRODUITES À PARTIR DE CEUX-CI

  摘要：

  本发明揭示了含有既有硫醇基团又有分子间硫醚基团的多硫醇组合物。还描述了生产这种多硫醇组合物的方法。

  公开号：

  WO2014078282A1

文献信息

• THIOL COMPOUNDS, SYNTHESIS METHOD THEREFOR, AND UTILIZATION OF SAID THIOL COMPOUNDS
  申请人：SHIKOKU CHEMICALS CORPORATION

  公开号：US20200369606A1

  公开（公告）日：2020-11-26

  The purpose of the present invention is to provide: novel thiol compounds; a method for synthesizing said thiol compounds; curing agents containing said thiol compounds; resin compositions containing said thiol compounds and an epoxy compound; and resin compositions containing said thiol compounds and an ene compound having a carbon-carbon double bond in a molecule. Furthermore, the purpose of the present invention is to provide adhesives and sealants having these resin compositions as ingredients. The thiol compounds of the present invention are represented by chemical formula (I) to chemical formula (VII).

  本发明的目的是提供：新型硫醇化合物；合成该硫醇化合物的方法；含有该硫醇化合物的固化剂；含有该硫醇化合物和环氧化合物的树脂组合物；以及含有该硫醇化合物和分子中含有碳碳双键的烯烃化合物的树脂组合物。此外，本发明的目的是提供将这些树脂组合物作为成分的粘合剂和密封剂。本发明的硫醇化合物由化学式(I)到化学式(VII)表示。
• Compositions for tissue augmentation
  申请人：Kuros Biosurgery AG

  公开号：US20030232944A1

  公开（公告）日：2003-12-18

  Methods for making biomaterials for augmentation of soft and hard tissues, kits containing precursors for forming the biomaterials, and the resulting biomaterials are described herein. The biomaterials are formed from at least a first and a second precursor component. The first precursor component contains at least two nucleophilic groups, and the second precursor component contains at least two electrophilic groups. The nucleophilic and electrophilic groups of the first and second precursor components form covalent linkages with each other at physiological temperatures. The precursors are selected based on the desired properties of the biomaterial. In the preferred embodiment, the first precursor is a siloxane. Optionally, the biomaterials contain additives, such as thixotropic agents, radiopaque agents, or bioactive agents. In the preferred embodiment, the biomaterials are used to augment at least one vertebra of the spine (vertebroplasty).

  本文描述了用于增强软组织和硬组织的生物材料制备方法，包含形成生物材料的前体物质的套件以及所得到的生物材料。生物材料由至少第一和第二前体成分形成。第一前体成分含有至少两个亲核基团，第二前体成分含有至少两个电子亲和基团。第一和第二前体成分的亲核和电子亲和基团在生理温度下形成共价键。前体物质根据所需的生物材料性质进行选择。在首选实施例中，第一前体是硅氧烷。可选地，生物材料包含添加剂，例如流变剂、放射性不透明剂或生物活性剂。在首选实施例中，生物材料用于增强脊柱的至少一个椎体（椎体成形术）。
• COMPOSITIONS FOR TISSUE AUGMENTATION
  申请人：Molenberg Aaldert Rens

  公开号：US20100034769A1

  公开（公告）日：2010-02-11

  Methods for making biomaterials for augmentation of soft and hard tissues, kits containing precursors for forming the biomaterials, and the resulting biomaterials are described herein. The biomaterials are formed from at least a first and a second precursor component. The first precursor component contains at least two nucleophilic groups, and the second precursor component contains at least two electrophilic groups. The nucleophilic and electrophilic groups of the first and second precursor components form covalent linkages with each other at physiological temperatures. The precursors are selected based on the desired properties of the biomaterial. In the preferred embodiment, the first precursor is a siloxane. Optionally, the biomaterials contain additives, such as thixotropic agents, radiopaque agents, or bioactive agents. In the preferred embodiment, the biomaterials are used to augment at least one vertebra of the spine (vertebroplasty).

  本文描述了用于增强软组织和硬组织的生物材料制备方法，包含形成生物材料的前体物质的套件，以及所得到的生物材料。生物材料由至少一个第一前体组分和一个第二前体组分形成。第一前体组分含有至少两个亲核基团，第二前体组分含有至少两个电离基团。第一和第二前体组分的亲核和电离基团在生理温度下形成共价键。前体物质的选择基于所需生物材料的性质。在首选实施例中，第一前体是硅氧烷。可选地，生物材料含有添加剂，例如流变剂、放射性不透明剂或生物活性剂。在首选实施例中，生物材料用于增强脊柱的至少一个椎体（椎体成形术）。
• Methods of mercaptanizing unsaturated compounds and compositions produced therefrom
  申请人：Chevron Phillips Chemical Company LP

  公开号：US10184055B2

  公开（公告）日：2019-01-22

  The present invention discloses polythiol compositions containing polythiol molecules having both thiol groups and intermolecular sulfide groups. Processes for producing such polythiol compositions also are described.

  本发明公开了含有同时具有硫醇基团和分子间硫化物基团的聚硫醇分子的聚硫醇组合物。本发明还描述了生产此类聚硫醇组合物的工艺。
• COMPOSITION FOR HARD TISSUE AUGMENTATION
  申请人：Kuros Biosurgery AG

  公开号：EP1494730B1

  公开（公告）日：2012-01-18